Strengthening Tuberculosis Diagnostics and Healthcare Amidst COVID-19: A Call to Action
DOI:
https://doi.org/10.31646/gbio.146Keywords:
Tuberculosis, COVID-19, Healthcare, Diagnosis, TreatmentAbstract
The COVID-19 pandemic has impeded various health systems worldwide, causing a decline in the surveillance, diagnosis and treatment of various other infectious diseases, including major diseases like Tuberculosis. The challenges associated with the pandemic have adversely impacted tuberculosis control efforts globally, resulting in a decline in tuberculosis detection, surveillance and healthcare provision. This is attributed to the redirection of diagnostic, healthcare and treatment services to the COVID-19 response, and the persistence of public stigma towards tuberculosis and COVID-19 patients, amongst other challenges. To avoid a further decline in tuberculosis control efforts, the necessary approaches recommended include improvement of tuberculosis detection by employing rapid diagnostic techniques, upgrading of treatment administration to reduce the risk of transmission and drug resistance, engagement of governments, policymakers and non-governmental bodies on the need for enhanced tuberculosis eradication strategies, and implementation of awareness campaigns to reduce the associated public stigma. As tuberculosis has remained a major public health threat over the years, it is pertinent to minimize the impediments and ensure continuity of global tuberculosis control efforts amidst the COVID-19 pandemic. This will ensure progress in line with the World Health Organization’s global strategy to end tuberculosis.Published
2022-03-10
How to Cite
Elebesunu, E. E., Ani, E. C., Anyabolo, E. E., Onyemeh, T. A., & Obeta, O. K. (2022). Strengthening Tuberculosis Diagnostics and Healthcare Amidst COVID-19: A Call to Action. Global Biosecurity, 4(1). https://doi.org/10.31646/gbio.146
Issue
Section
Editorials and Commentaries
License
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2021-12-19
Accepted 2022-02-08
Published 2022-03-10
Accepted 2022-02-08
Published 2022-03-10